ArticleCities (London, England)2022
A systematic review of the impacts of the coronavirus crisis on urban transport: Key lessons learned and prospects for future cities.
Article in Cities (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Modelling the spread of infectious diseases in public transport systems under varying demand patterns and capacity constraints.Scientific reports · 2025Article
- The bidirectional effects of the COVID-19 pandemic on the social determinants of health among refugees and internally displaced persons in low and lower-middle income countries: A systematic review of qualitative studies.Journal of migration and health · 2025Review
- Multi-dimensional impact of COVID-19 on active mobility in urban China: a scoping review of empirical knowledge.Frontiers in public health · 2024Article
- COVID-19, Cities and Inequality.Applied geography (Sevenoaks, England) · 2023Article
- A study on the factors that influenced the choice of transport mode before, during, and after the first lockdown in Milan, Italy.Cities (London, England) · 2023Article
- Monkeypox caused less worry than COVID-19 among the general population during the first month of the WHO Monkeypox alert: Experience from Saudi Arabia.Travel medicine and infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic continues to have a significant impact on the transport sector worldwide. Lockdown and physical distancing requirements continue to be enforced in many cities leading to severe travel restrictions and travel demand reduction to limit the spread of the disease. This article provides bibliometric evidence-based insights into how the pandemic has exposed the vulnerability of established public transport systems and shared mobility solutions. It shows how some transport interventions can accelerate the shift to sustainable urban mobility practices such as micro-mobility and active transport. To accomplish this, the article examines recent studies (244 publications) from the Scopus database using a rigorous systematic literature review approach covering the period from January 2020 to February 2021. Importantly, the mapping of bibliographic coupling and co-citation analysis showed four heterogeneous clusters representing research efforts into "environment", "travel behavior and mode choice", "public transport", and "interventions". Inductive reasoning is used to analyze the disruptions that cities have encountered worldwide, the rapid interventions that were put in place, the aftershocks and the short and long-term impacts. Finally, the paper summarizes the lessons learned and opportunities ahead, and the challenges that must be overcome. The article also outlines pathways to build on the momentum of sustainable practices as part of a holistic approach for enabling resilient transport solutions for the new urban world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.